CPRX — CATALYST PHARMACEUTICALS INC

Ownership history in Fundsmith LLP  ·  4 quarters on record

This page tracks every 13F SEC filing in which Fundsmith LLP reported a position in CATALYST PHARMACEUTICALS INC (CPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.46% (2025 Q4)
Avg. % of fund
0.32%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 3,363,807 — 0% 0.46% $78.5M $23.34
2025 Q3 ADDED 3,363,807 +654,721 +24.2% 0.33% $66.3M $19.70
2025 Q2 ADDED 2,709,086 +557,812 +25.9% 0.26% $58.8M $21.70
2025 Q1 INITIATED 2,151,274 — — 0.24% $52.2M $24.25
% of Fund (quarterly)    CPRX price (monthly, adj. close)

Other funds also holding CPRX

As of 2025 Q4 — sorted by position size

TANAKA CAPITAL MANAGEMENT INC 3Y 7Y 4.87% GABLES CAPITAL MANAGEMENT INC. 3Y 7Y 4.19% JW Asset Management, LLC 3Y 7Y 2.95% Knott David M Jr 3Y 2.04% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.46% QSV Equity Investors LLC 1.24% Bridge City Capital, LLC 3Y 7Y 1.07% GLOBEFLEX CAPITAL L P 3Y 7Y 1.04% JUNCTURE WEALTH STRATEGIES, LLC 3Y 7Y 0.65% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.6%
← Back to Fundsmith LLP Holdings